Home Study Details

    Program Type

    Home Study Webcast


    2 Contact Hour(s)

    Release Date

    Thursday, April 20, 2023

    Offline Date

    Monday, April 20, 2026

    ACPE Expiration Date

    Monday, April 20, 2026

    Target Audience




    • Overview

      How can I best help my patient while navigating the abundance of federal and state laws dictating how I practice? Will I lose my license? Just how far is too far?

      No one ever enjoys the answer to difficult patient care scenarios being the cookie-cutter response: it differs patient to patient. Yet, just how does one make recommendations to provide patient care while still adhering to the “corresponding responsibility” of prescribers and dispensers and accounting for reasonable patient variations? Well, as always, an ounce of prevention (education) is worth a pound of treatment (patient care). Join Dr. Mark Garofoli for a dynamic discussion on drug diversion best practices (DEA Red Flags, PDMPs, Urine Drug Monitoring, etc.) along with best practices in patient education and treatment selection.


      • Slide Document :   23127H99_2pp.pdf
      • Slide Document :   23127H99_6pp.pdf

      Financial Support By

    • Pharmacist

      Recall patient care best practices in regards to patient education (contracts, treatment goals, and medication storage and disposal) and treatment selection (mental health assessments, drug interaction reviews, and naloxone education)
      Recall “DEA Red Flags” for prescribers and dispensers
      Identify the clinical practice implication differences between urine drug screenings (UDS) and urine drug tests (UDT)
      Recognize appropriate actions for a pharmacist related to the federally mandated corresponding responsibility to ensure the legitimate medical purpose and usual course of practice for any given prescription
      Recognize the utility of Prescription Drug Monitoring Programs (PDMPs) in preventing drug diversion
      Recall appropriate substance-use disorder and drug diversion/abuse referral resources for patients and healthcare professionals alike
    • Activity Type


      CE Broker


      Universal Activity Number

      Pharmacist 0798-0000-23-127-H99-P

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones

    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Firefox 3.0.3 or higher

    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).